Results 101 to 110 of about 1,312,052 (154)

Pharmacogenomic landscape of TNF inhibitors in the Middle Eastern Qatari population. [PDF]

Front Immunol
Jan Z, Velayutham D, QPGx-TNFi Consortium , Mifsud B, Jithesh PV.   +4 more
europepmc   +1 more source

Comparative safety of JAK inhibitors versus TNF inhibitors in psoriatic arthritis: a real-world propensity score-matched cohort study. [PDF]

Ann Med Surg (Lond)
Gautam N, Subedi BK, Dhungana R, Pokhrel N, Gupta Rauniyar SP, Surendra KC, Thapa SB.   +6 more
europepmc   +1 more source

Efficacy and safety of dual-targeted therapy with tofacitinib and TNF inhibitors in refractory spondyloarthritis: a case series from a tertiary care center. [PDF]

Ther Adv Musculoskelet Dis
Agrawal A, Yadav SS, Balakrishnan C.
europepmc   +1 more source

Correlations between serum 25-hydroxyvitamin D levels and nailfold microvascular changes in psoriatic arthritis patients with distal interphalangeal arthritis treated with TNF inhibitors. [PDF]

Front Immunol
Anghel D, Cobilinschi CO, Prioteasă OG, Opriş-Belinski D, Săulescu IC, Groşeanu ML, Bobircă A, Bojincă VC.   +7 more
europepmc   +1 more source

Dual effects of JAK vs TNF inhibitors on osteoporosis, fractures and mortality in rheumatoid arthritis: a real-world cohort study. [PDF]

Front Immunol
Huang C, Hong D, Hung YM, Wang SI, Wei JC, Chen X.   +5 more
europepmc   +1 more source

Persistence of IL-17 and TNF inhibitors following initial TNF inhibitor use in axial spondyloarthritis: a nationwide retrospective cohort study. [PDF]

Ther Adv Musculoskelet Dis
Jung YS, Cho SK, Choi SR, Jung SY, Sung YK.   +4 more
europepmc   +1 more source

The association between ethnicity, socioeconomic position and outcomes following initiation of TNF inhibitors in juvenile idiopathic arthritis: results from the UK JIA Biologics Register. [PDF]

Rheumatology (Oxford)
Beesley RP, Baildam E, Beresford MW, Douglas S, Southwood TR, UK JIA Biologics Register, Hyrich KL, Humphreys JH, Kearsley-Fleet L.   +8 more
europepmc   +1 more source

Subclinical atherosclerosis in patients with hidradenitis suppurativa treated with TNF inhibitors. [PDF]

Skin Res Technol, 2023
Oba MC, Askin O, Gunver MG, Kocaarslan G, Alis DC, Engin B.   +5 more
europepmc   +1 more source

Optimization of a synoviocyte-targeted biologic for inflammatory arthritis in combination or bispecific administration with TNF inhibitors. [PDF]

JCI Insight
Ramsey SH, Zhao Z, Lee MC, Hein da Rosa T, Schneider AC, Bollmann M, Dada N, Frizzi KE, Han MM, Kim J, Zoccheddu M, Calcutt NA, Firestein GS, Bryson JW, Svensson MN, Santelli E, Stanford SM, Bottini N.   +17 more
europepmc   +1 more source

The Association Between Serum Drug Concentration and a Flare in Rheumatoid Arthritis Patients Tapering TNF Inhibitors. [PDF]

Pharmaceuticals (Basel)
Layegh Z, Hooijberg F, Boekel L, Looijen AEM, van Mulligen E, Loeff FC, Dijk L, Dolhain RJEM, Rispens T, Wolbink GJ, de Jong PHP.   +10 more
europepmc   +1 more source